Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Can specific axillary radiotherapy be omitted in undissected, clinically node-negative patients who undergo breast-conserving therapy?

Can specific axillary radiotherapy be omitted in undissected, clinically node-negative patients who undergo breast-conserving therapy? Ann Surg Oncol. 2002 Mar; 9(2):117-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.